New International Speakers:
鈥� Motivational Keynote Speaker
鈥� World or European Customs Officials
鈥� Cross Industry Case Studies from Food and Fine Arts
鈥� Sophisticated Supply Chain Case Studies
New Programme Topics:
鈥� International Cold Chains - Gaining Regulatory Feedback from UK, US,
Europe, China, South America and India
鈥� Target China - A Seminar on how to Handle Customs Challenges, Evolving
Regulatory Expectations, Identify Suitable Freight Forwarders, Brokers and
Transport Partners
鈥� Transport of Biopharmaceutical Products - Exploring Cost-Effective
Options for Qualified Shipping of Bulk Products
鈥� Downstream Distribution and the Last Miles of the Cold Chain - How can
we gain Greater Control of Valuable, Needed Medicines in the Last Leg of
our Supply Chains?
www.coolchaineurope.com
+44 (0) 207 368 9300
Enquire@iqpc.co.uk
'Some of the speakers had really good knowledge. Really good forum for benchmarking and networking. I will come back.'
Cazaux Maleville Sabine, Johnson & Johnson
'It's a good mix of customers (pharma), authorities/regulations and service providers.'
Jens Lamberth, AstraZeneca AB
鈥� Motivational Keynote Speaker
鈥� World or European Customs Officials
鈥� Cross Industry Case Studies from Food and Fine Arts
鈥� Sophisticated Supply Chain Case Studies
New Programme Topics:
鈥� International Cold Chains - Gaining Regulatory Feedback from UK, US,
Europe, China, South America and India
鈥� Target China - A Seminar on how to Handle Customs Challenges, Evolving
Regulatory Expectations, Identify Suitable Freight Forwarders, Brokers and
Transport Partners
鈥� Transport of Biopharmaceutical Products - Exploring Cost-Effective
Options for Qualified Shipping of Bulk Products
鈥� Downstream Distribution and the Last Miles of the Cold Chain - How can
we gain Greater Control of Valuable, Needed Medicines in the Last Leg of
our Supply Chains?
www.coolchaineurope.com
+44 (0) 207 368 9300
Enquire@iqpc.co.uk
'Some of the speakers had really good knowledge. Really good forum for benchmarking and networking. I will come back.'
Cazaux Maleville Sabine, Johnson & Johnson
'It's a good mix of customers (pharma), authorities/regulations and service providers.'
Jens Lamberth, AstraZeneca AB
